An in-depth look to EASTWOOD BIO-MED CDA INC operating, investing, and financing activities

EBM free cash flow for Q3 24 is -17.58 k CAD. For 2023, EBM free cash flow was -16.89 k CAD and operating cash flow was -16.89 k CAD.